FINWIRES · TerminalLIVE
FINWIRES

Tsukishima Lifts Full-Year Profit Forecast on Backlog Execution and Share Sales

-- Tsukishima (TYO:6332) now expects full-year profit attributable to owners of parent to reach 16.9 billion yen for the fiscal year ended March 31, up from its previous forecast of 15 billion yen.

The water equipment manufacturer raised earnings per share forecasts to 412.43 yen from 380.64 yen initially and net sales estimates to 149 billion yen from 144 billion yen, according to a Tokyo bourse filing on Thursday.

The upward revision is driven by progress in executing a substantial backlog of received orders, which has boosted net sales, operating profit, and ordinary profit.

Additionally, the company recorded higher extraordinary income from the sale of cross-shareholdings, contributing to the profit increase.

As a result, Tsukishima raised its year-end dividend forecast to 43 yen per share from 40 yen per share previously, bringing the total annual dividend to 85 yen per share, higher than the 78 yen paid in the prior fiscal year.

Related Articles

Australia

Boston Scientific 2026 Guidance Cut 'Prudent,' Q2 Trough Expected, RBC Says

Boston Scientific (BSX) posted Q1 sales and earnings per share beats alongside a "prudent" guidance cut, with Q2 expected to be the trough quarter, RBC Capital Markets said in a note Wednesday.The analysts said management lowered 2026 organic growth outlook to 6.5% to 8% due to "unanticipated headwinds" and "changing business patterns," though many investors already expected a reset, including those who believed the company could make the numbers to reset the base.The analysts called Q1 a "clearing event," with Boston Scientific reporting Electrophysiology growing 21.7% year-over-year on an organic basis versus 18.5% consensus, while Watchman grew 18.8% versus 21.5% consensus, broadly in line with expectations."Looking ahead, we view Q2 as a trough quarter (guided 5% to 7%) with improving growth thereafter aided by new products, improvement in base businesses, and Watchman growth in low double digits. We would be buyers at current valuations," the analysts said.RBC reiterated its outperform rating on Boston Scientific and adjusted its price target to $100 from $105.Price: $65.76, Change: $+0.89, Percent Change: +1.37%

$BSX
Australia

Wendy's Expected to Face Another Challenging Top-Line Quarter, RBC Capital Markets Says

Wendy's (WEN) is set up for another challenging top-line quarter, with a slight Q1 US same store sales miss, though some directional improvement is anticipated, RBC Capital Markets said in a note Wednesday.The brokerage said Q1 results will reflect whether management's turnaround plan is gaining traction in franchisee locations, as company-operated stores have been outperforming franchisees over the past couple of quarters. The key metric will be franchisee comp relative to company-operated, RBC said.After the company updated its menu in 2025, the brokerage said it is looking for improved consumer value perceptions and higher traffic.Wendy's plans to close 5% to 6% of total US stores, primarily in H1, focusing on its worst performing locations and expecting an impact on its global sales and full-year EBITDA, according to the note.The company's international segment continues to grow, though driven by lower average unit volume markets like Latin America and Asia Pacific, which is dilutive to system sales, while flat population growth in Canada, which contributes about half of international sales, could pose a headwind to same-store-sales growth, the brokerage said.RBC Capital Markets maintained a sector perform rating on Wendy's, with a price target of $8.Shares of Wendy's were down 1.3% in Thursday trading.Price: $7.01, Change: $-0.09, Percent Change: -1.27%

$WEN
Australia

DigitalBridge Gets Stockholder Approval for Acquisition by SoftBank Group

DigitalBridge Group (DBRG) said Thursday its stockholders voted to approve the acquisition of the company by SoftBank Group at a virtual special meeting of stockholders.As per the acquisition agreement, DigitalBridge stockholders will receive $16 per share in cash upon transaction close, the company said.Approximately 96% of the votes cast favored the acquisition, satisfying the requirement for approval by a majority of shareholders, the company said.The transaction is expected to close in the second half, subject to customary closing conditions and regulatory approvals, according to a statement.Price: $15.62, Change: $+0.01, Percent Change: +0.03%

$DBRG